NCT04519788View on ClinicalTrials.gov

AT-301 Nasal Spray in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

December 8, 2020

Study Completion Date

January 12, 2021

Conditions
Healthy
Interventions
DRUG

AT-301B

Nasal Spray

DRUG

AT-301A

Nasal Spray

Trial Locations (1)

5000

CMAX Clinical Research, Adelaide

Sponsors
All Listed Sponsors
lead

Atossa Therapeutics, Inc.

INDUSTRY